pc:quell

Quell Therapeutics

80 Wood Lane, Translation & Innovation Hub, Imperial College White City Campus, London, London W12 0BZ, GB

https://www.quell-tx.com/

Quell Therapeutics is a biotechnology company developing engineered regulatory T cell (Treg) therapies aimed at treating autoimmune and inflammatory diseases. The company employs a cell‑engineering platform to generate and optimize antigen‑specific Tregs designed to restore immune tolerance and achieve targeted, durable immune regulation with reduced broad immunosuppression.

Leadership & Board

Current Number of Employees120

Current LinkedIn Followers20,054

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$156M

Total Amount Raised$156M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$156M

Latest Funding Amount$156M

Latest Funding RoundSeries B

Latest Funding RoundSeries B

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Dec 29, 2021

Series B

$156.00M

―

Investors

SV Health Investors

Series B

Series B

Related News and Analysis

SynergySuite Gains FoodTech 500 Recognition as It Pushes Mobile-First, Real-Time Restaurant Ops Platform

SynergySuite Gains FoodTech 500 Recognition as It Pushes Mobile-First, Real-Time Restaurant Ops Platform

SynergySuite, a provider of AI-powered restaurant back-of-house management software, was featured this week for both product positioning and...

3h ago

Casca – Weekly Recap

Casca – Weekly Recap

Casca is an AI-driven lending technology company, and this weekly summary reviews its notable developments over the past...

3h ago

Toteai – Weekly Recap

Toteai – Weekly Recap

Toteai is an AI-focused retail technology company, and this weekly summary reviews its latest positioning in the fuel...

3h ago

Polestar Analytics Advances AI Platform Strategy and Enterprise Positioning With New Launches and Events

Polestar Analytics Advances AI Platform Strategy and Enterprise Positioning With New Launches and Events

Polestar Analytics is featured this week for a mix of product innovation, ecosystem positioning, and brand-building activity. The...

3h ago

Medallion Underscores Financial Impact of Hospital Credentialing Delays in Weekly Commentary

Medallion Underscores Financial Impact of Hospital Credentialing Delays in Weekly Commentary

Medallion is a healthcare operations and credentialing platform, and this weekly recap reviews its latest commentary on hospital...

3h ago

Gen Phoenix Showcases New Sustainable Cabin Finishes and CirculAir Playbook at Aircraft Interiors Expo 2026

Gen Phoenix Showcases New Sustainable Cabin Finishes and CirculAir Playbook at Aircraft Interiors Expo 2026

Gen Phoenix featured prominently at the Aircraft Interiors Expo 2026 in Hamburg, where it highlighted strong industry interest...

3h ago

Pyx Health Leverages DSNP Quality Gains and RISE Sponsorship to Deepen SNP Market Reach

Pyx Health Leverages DSNP Quality Gains and RISE Sponsorship to Deepen SNP Market Reach

Pyx Health is emerging as a more prominent player in the Special Needs Plan space this week, centering...

3h ago

Frinks AI Sharpens 3D Inspection Focus to Boost Electronics Manufacturing Quality

Frinks AI Sharpens 3D Inspection Focus to Boost Electronics Manufacturing Quality

Frinks AI is a computer-vision company focused on applying 3D inspection to improve quality in printed circuit board...

3h ago

Coworkerai – Weekly Recap

Coworkerai – Weekly Recap

Coworkerai is highlighting its push into AI-native workflows this week, with a particular focus on software engineering and...

3h ago

Kollegio Highlights Awards Recognition, SKEMA Partnership, and Karachi AI Hub in Growth Push

Kollegio Highlights Awards Recognition, SKEMA Partnership, and Karachi AI Hub in Growth Push

Kollegio spent the week spotlighting three pillars of its growth strategy: international recognition, global partnerships, and a distributed...

3h ago